In plain words

Four randomized trials, each lasting a few months, found lower cholesterol or triglycerides with berberine than with placebo, lifestyle change or metformin. Two studies without a comparison group also saw levels fall. The trials were small and short.

The short answer

All four randomized trials, lasting 3 months to 16 weeks, found lower lipids with berberine against placebo, metformin or lifestyle change: 116 people on 1.0 g a day (2008), 59 and 61 women with PCOS with no dose in the ledger (2011), 184 people (2015) and 36 people (2008) on 500 mg three times a day. Two before-after studies with no control group, in 32 and 48 people over 3 months, saw falls too. Certainty is low, because the trials are small and short.

Where the evidence sits

Lipids fell

■ Randomized trial, Zhang et al., 2008 · 116 people · 3 months
■ Randomized trial, Wei et al., 2011 · 59 people · 3 months
■ Randomized trial, Yan et al., 2015 · 184 people · 16 weeks
■ Randomized trial, Yin, 2008 · 36 people · 13 weeks
■ Before-after study, Yin, 2008 · 48 people · 3 months
■ Before-after study, Kong et al., 2004 · 32 people · 3 months
◪ Pooled analysis, Dong et al., 2013 · may overlap studies counted here
◪ Pooled analysis, Dong, 2012 · may overlap studies counted here

No significant change

◪ Pooled analysis, Dong, 2012 · may overlap studies counted here

■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data

Evidence weight7777 / 100?

Who says what

SourceFindingDesignPeopleDose and lengthFunding and independence
Zhang et al., 2008Lower cholesterolRandomized, against placebo1161.0 g a day, 3 monthsNot in ledger
Wei et al., 2011Lower cholesterol and triglyceridesRandomized, against placebo and metformin59 and 61 women with PCOS3 months; dose not in ledgerNot in ledger
Yan et al., 2015Larger falls than lifestyle changeRandomized, against lifestyle change18416 weeksNot in ledger
Yin et al., 2008Lower than metformin; fell from baseline as add-onRandomized, against metformin; separate before-after study36; 48500 mg three times a day, 13 weeks; 3 monthsNot in ledger
Kong et al., 2004Fell from baselineBefore-after study, no control group323 monthsNot in ledger
Dong et al., 2012Lower with lifestyle change; no significant change added to diabetes drugsMeta-analysis that may include the trials above271 in one comparison12 weeks in one comparisonNot in ledger
Dong et al., 2013Lower cholesterolMeta-analysis that may include the trials above874Not in ledgerNot in ledger
Zhang et al., 2008

Lower cholesterol

Design
Randomized, against placebo
People
116
Dose and length
1.0 g a day, 3 months
Funding
Not in ledger
Wei et al., 2011

Lower cholesterol and triglycerides

Design
Randomized, against placebo and metformin
People
59 and 61 women with PCOS
Dose and length
3 months; dose not in ledger
Funding
Not in ledger
Yan et al., 2015

Larger falls than lifestyle change

Design
Randomized, against lifestyle change
People
184
Dose and length
16 weeks
Funding
Not in ledger
Yin et al., 2008

Lower than metformin; fell from baseline as add-on

Design
Randomized, against metformin; separate before-after study
People
36; 48
Dose and length
500 mg three times a day, 13 weeks; 3 months
Funding
Not in ledger
Kong et al., 2004

Fell from baseline

Design
Before-after study, no control group
People
32
Dose and length
3 months
Funding
Not in ledger
Dong et al., 2012

Lower with lifestyle change; no significant change added to diabetes drugs

Design
Meta-analysis that may include the trials above
People
271 in one comparison
Dose and length
12 weeks in one comparison
Funding
Not in ledger
Dong et al., 2013

Lower cholesterol

Design
Meta-analysis that may include the trials above
People
874
Dose and length
Not in ledger
Funding
Not in ledger

What did the randomized trials find?

Zhang and colleagues (2008) gave 116 people 1.0 g of berberine a day or placebo for 3 months, and total cholesterol fell in the berberine group:

total cholesterol from 5.31 +/- 0.98 to 4.35 +/- 0.96 mm/liter

Wei and colleagues (2011) compared berberine with placebo in 59 women with PCOS and with metformin in 61 over 3 months, with no dose in the ledger; lipids favored berberine both times. Yan and colleagues (2015) report larger falls in triglycerides and cholesterol than with lifestyle change alone, in 184 people over 16 weeks. Yin and colleagues (2008) found triglycerides and total cholesterol lower than with metformin in 36 people on 500 mg three times a day for 13 weeks.

What did studies without a control group find?

Kong and colleagues (2004) measured 32 people with high cholesterol before and after 3 months of berberine, with no dose in the ledger:

Oral administration of BBR in 32 hypercholesterolemic patients for 3 months reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%.

In a separate before-after study, Yin and colleagues (2008) gave 500 mg three times a day as add-on therapy to 48 people, and after 3 months lipids were below baseline.

Do the meta-analyses agree?

Both meta-analyses pooled trials that may include the trials above. Dong and colleagues (2012) found lower triglycerides and LDL when berberine joined lifestyle change (271 people, 12 weeks, no dose in the ledger), and no significant change in the trials that added it to diabetes drugs. Dong and colleagues (2013) pooled randomized trials in 874 people, with no dose or duration in the ledger, and concluded:

In conclusion, berberine may have beneficial effects in the control of blood lipid levels.

Why the sources disagree

The independent studies point the same way. The one result without a significant change is in Dong and colleagues (2012), a pooled estimate that may include the trials above, where berberine was added to diabetes drugs rather than tested against placebo, metformin or lifestyle change. The people also differ: women with PCOS (2011) and people with high cholesterol (2004). The longest trial ran 16 weeks.

What would settle it

An independently funded, pre-registered randomized trial of berberine at 1.0 g a day against placebo in adults with high LDL cholesterol, lasting 12 months and reporting LDL, triglycerides and HDL at 3, 6 and 12 months. A lasting LDL difference repeated by a second research group would raise certainty above low; no difference at 12 months would weaken the shorter trials.

How this page was made

The 7 sources were chosen from a PubMed search: five that measured blood lipids in people directly and two meta-analyses that may include their trials. Four search results were left out because they studied cells and animals, other diseases, or a berberine salt. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.

Changelog: 30 Sep 2026, first version, 7 sources.